CEBPB, CEBPD, GATA3, KLF4, and H4C11 were the genes identified by our transcriptomics analysis of the NAFLD samples, which were primarily involved in immune cells and had been identified as a target by several disease studies. The gene discussed is H4C11; the disease is metabolic dysfunction-associated steatotic liver disease.